Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of patient-centered pharmaceutical care on drug therapy and health-related quality of life and medication adherence in patients with major depressive disorder
TCTR20220701001Phase 4Recruiting
- Sponsor
- N/A
- Start
- Jun 2022
- Countries
- 1
01
Overview
Phase 4 trial in major depressive disorder (MDD), sponsored by N/A. Primary endpoints: Drug therapy outcomes, Health-related quality of life and 1 more. Started Jun 2022; status: recruiting.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on TCTR20220701001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220701001.